Kazazian Asset Management LLC bought a new position in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 32,147 shares of the company’s stock, valued at approximately $2,891,000. DocuSign makes up 2.2% of Kazazian Asset Management LLC’s investment portfolio, making the stock its 11th biggest holding.
A number of other large investors have also bought and sold shares of DOCU. Citizens Financial Group Inc. RI boosted its position in DocuSign by 2.3% during the 4th quarter. Citizens Financial Group Inc. RI now owns 5,990 shares of the company’s stock worth $539,000 after acquiring an additional 133 shares during the last quarter. Rakuten Securities Inc. boosted its position in DocuSign by 20.9% during the 4th quarter. Rakuten Securities Inc. now owns 797 shares of the company’s stock worth $72,000 after acquiring an additional 138 shares during the last quarter. Synergy Financial Group LTD boosted its position in DocuSign by 3.4% during the 4th quarter. Synergy Financial Group LTD now owns 4,241 shares of the company’s stock worth $381,000 after acquiring an additional 140 shares during the last quarter. M&T Bank Corp boosted its position in DocuSign by 1.3% during the 4th quarter. M&T Bank Corp now owns 10,840 shares of the company’s stock worth $975,000 after acquiring an additional 143 shares during the last quarter. Finally, Avior Wealth Management LLC boosted its position in DocuSign by 36.5% during the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after acquiring an additional 145 shares during the last quarter. 77.64% of the stock is owned by institutional investors.
DocuSign Price Performance
Shares of DocuSign stock opened at $85.01 on Wednesday. The business has a fifty day simple moving average of $87.75 and a two-hundred day simple moving average of $79.87. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86. The company has a market capitalization of $17.17 billion, a price-to-earnings ratio of 17.53, a P/E/G ratio of 6.94 and a beta of 1.02.
Wall Street Analyst Weigh In
DOCU has been the subject of a number of recent research reports. Citigroup upped their price target on DocuSign from $113.00 to $115.00 and gave the stock a “buy” rating in a research report on Friday, March 14th. UBS Group reduced their price target on DocuSign from $100.00 to $90.00 and set a “neutral” rating for the company in a research report on Friday, March 14th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $90.00 price target on shares of DocuSign in a research report on Friday, March 14th. Wells Fargo & Company increased their price objective on DocuSign from $70.00 to $73.00 and gave the company an “underweight” rating in a report on Friday, March 14th. Finally, Wedbush reissued a “neutral” rating and issued a $100.00 price objective on shares of DocuSign in a report on Friday, March 14th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $95.00.
View Our Latest Stock Analysis on DocuSign
Insider Buying and Selling at DocuSign
In other DocuSign news, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the transaction, the chief executive officer now owns 156,050 shares in the company, valued at $14,050,742. This trade represents a 20.40 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $90.17, for a total value of $676,275.00. Following the transaction, the insider now owns 43,781 shares in the company, valued at $3,947,732.77. The trade was a 14.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 66,034 shares of company stock valued at $5,932,352 in the last quarter. 1.66% of the stock is currently owned by insiders.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than DocuSign
- ESG Stocks, What Investors Should Know
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Capture the Benefits of Dividend Increases
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.